It presents in two forms
By week 4, approximately 70% of patients report nausea has resolved or become minimal, though some individuals continue experiencing mild queasiness into week 6
130 days: injection site pruritus, ROR 2.478, 95% CI 1.5214.034, P 30 days vs
We used the following keywords: GLP-1, GLP-1 receptor agonist, exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, dulaglutide, efpeglenatide, coronary artery disease, coronary atherosclerosis, endothelial dysfunction, inflammation, body weight, blood pressure, lipids, aggregation, coagulation, coronary vasospasm, coronary vasodilation, coronary microvascular, acute coronary syndrome, myocardial infarction, unstable angina, stable angina, chronic coronary syndrome, vasospastic angina, microvascular angina, coronary revascularization